Basic information
Biomarker: cyclin H
Histology type: benign tumor
Cohort characteristics
Country: Turkey
Region: Adana
Study type: Comparative Study
Followed up time :
Total number | Group I | Group I number | Group II | Group II number | Group III | Group III number | Group IV | Group IV number |
---|---|---|---|---|---|---|---|---|
39 | endometrial adenocarcinoma | 29 | normal endometrium | 10 |
Sample information
Conclusion: It might be one of the biomarkers for determining proliferative activity in endometrial hyperplasia and endometrioid adenocarcinoma.
Sample type : tissue
Sample method: immunohistochemistry
Expression pattern : expression
Expression elevation: Every stained slide was assessed and given a score in which the intensity of the staining (no staining = 0, weak staining =1, medium staining = 2, and strong staining= 3) and the percentage of stained cells (0% = 0, 1–24% = 1, 25–49% = 2, 50–74% = 3, and greater than 75% = 4) were multiplied. With the system, the maximum score was 12 (with over 75% of the cells showing strong staining) and the minimum score was 0 (negative staining).Data were expressed as mean ± SD, median (minimum to maximum), n (number of cases), and percentage (%). Bonferroni’s correction was applied (P <0.05/n, where n - number of comparisons) when multiple comparisons were made
Disease information
Related information
Funtion Uniprot: Regulates CDK7, the catalytic subunit of the CDK-activating kinase (CAK) enzymatic complex. CAK activates the cyclin-associated kinases CDK1, CDK2, CDK4 and CDK6 by threonine phosphorylation. CAK complexed to the core-TFIIH basal transcription factor activates RNA polymerase II by serine phosphorylation of the repetitive C-terminal domain (CTD) of its large subunit (POLR2A), allowing its escape from the promoter and elongation of the transcripts. Involved in cell cycle control and in RNA transcription by RNA polymerase II. Its expression and activity are constant throughout the cell cycle.
UniProt ID: P51946
UniProt Link: https://www.uniprot.org/uniprotkb/P51946/entry
Biological function from UniProt: #Cell cycle #Transcription #Transcription regulation
Molecular function from UniProt:
Subcellular UniProt: #Nucleus
Alternative name from UniProt:
Recommended name: Cyclin-H
Gene name from HGNC: CCNH (CycH, p34, p37)
HPA class: Cancer-related genes
AlphaFold DB: P51946
AlphaFold Link: https://alphafold.ebi.ac.uk/entry/P51946
HPA link: https://www.proteinatlas.org/ENSG00000134480-CCNH
Tissue specificity RNA from HPA: Low tissue specificity
Tissue expression from HPA: Nuclear expression in several tissues.
Single cell type specificity Cell type enhanced (Early spermatids, Plasma cells, T-cells, Spermatocytes)
Immune cell specificity: Low immune cell specificity
Subcellular summary HPA Located in Nucleoplasm
Cancer prognostic summary HPA Prognostic marker in renal cancer (unfavorable) and ovarian cancer (unfavorable)
Pathology link: https://www.proteinatlas.org/ENSG00000134480-CCNH/pathology
Pathology endo: https://www.proteinatlas.org/ENSG00000134480-CCNH/pathology/endometrial+cancer
OMIM: 601953
OMIM link2: https://www.omim.org/entry/601953
HGNC ID: HGNC:1594
HGNC link: https://www.genenames.org/data/gene-symbol-report/#!/hgnc_id/HGNC:1594